ProfileGDS5678 / 1417487_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 22% 23% 21% 23% 23% 22% 22% 23% 23% 23% 23% 23% 22% 23% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.548322
GSM967853U87-EV human glioblastoma xenograft - Control 22.5386623
GSM967854U87-EV human glioblastoma xenograft - Control 32.5016121
GSM967855U87-EV human glioblastoma xenograft - Control 42.4915623
GSM967856U87-EV human glioblastoma xenograft - Control 52.5020623
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5755222
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5425222
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5176923
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.508923
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.5278823
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5236823
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5193223
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5256722
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.5276423